Home › 2017 › Sanofi › Andreas Evers

AE

Andreas Evers — 11 Patents in 2017

SASanofi: 11 patents #1 of 232Top 1%

Frankfurt am Main, DE: #3 of 222 inventorsTop 2%

Overall (2017): #6,367 of 506,227Top 2%

11 Patents 2017

Issued Patents 2017

Showing 1–11 of 11 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
9834527	Macrocyclic urea derivatives as inhibitors of TAFIa, their preparation and their use as pharmaceuticals	Christopher Kallus, Michael Wagner, Hermut Wehlan	2017-12-05	$11,040,000
9789165	Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists	Dieter Kadereit, Katrin Lorenz, Torsten Haack, Michael Wagner, Bernd Henkel +2 more	2017-10-17	$7,245,000
9775904	Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists	Martin Bossart, Ralf Elvert, Torsten Haack, Siegfried Stengelin, Michael Wagner	2017-10-03	$8,333,000
9771406	Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4	Martin Bossart, Ralf Elvert, Torsten Haack, Siegfried Stengelin, Michael Wagner +1 more	2017-09-26	$18,404,000
9758561	Dual GLP-1/glucagon receptor agonists derived from exendin-4	Martin Bossart, Ralf Elvert, Torsten Haack, Siegfried Stengelin, Michael Wagner +1 more	2017-09-12	$14,166,000
9751926	Dual GLP-1/GIP receptor agonists	Dieter Kadereit, Katrin Lorenz, Torsten Haack, Michael Wagner, Bernd Henkel +2 more	2017-09-05	$7,330,000
9750788	Non-acylated exendin-4 peptide analogues	Dieter Kadereit, Katrin Lorenz, Torsten Haack, Michael Wagner, Bernd Henkel +2 more	2017-09-05	$7,330,000
9745360	Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists	Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Martin Lorenz +1 more	2017-08-29	$18,132,000
9694053	Dual GLP-1/glucagon receptor agonists	Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Martin Bossart +1 more	2017-07-04
9688645	Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa	Christopher Kallus, Mark Broenstrup, Anja Globisch, Herman Schreuder, Michael Wagner	2017-06-27	$8,363,000
9670261	Functionalized exendin-4 derivatives	Torsten Haack, Michael Wagner, Bernd Henkel, Siegfried Stengelin, Martin Lorenz +1 more	2017-06-06	$14,464,000